Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2026
- #644
- Final score
- 43.57
- Years on list
- 7
↗ Climbed 96 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 96 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 59 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 83 since 2020
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2026
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | TECH | INCY | BIO |
|---|---|---|---|
| Climate Change | 48.1 | 64.4 | 45.4 |
| Employee Relations | 48.3 | 55.9 | 38.6 |
| Environment | 25.8 | 37.2 | 21.8 |
| Stakeholders & Society | 52.3 | 27.0 | 40.3 |
| Human Rights | 38.3 | 8.3 | 32.0 |
| Governance | 46.9 | 48.6 | 42.7 |
| Performance Rating | 54.0 | 51.1 | 46.0 |